首页> 美国卫生研究院文献>PLoS Pathogens >Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein
【2h】

Urea-Mediated Cross-Presentation of Soluble Epstein-Barr Virus BZLF1 Protein

机译:尿素介导的可溶性爱泼斯坦-巴尔病毒BZLF1蛋白的交叉表达

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Soluble extracellular proteins usually do not enter the endogenous human leukocyte antigen (HLA) I–dependent presentation pathway of antigen-presenting cells, strictly impeding their applicability for the re-stimulation of protein-specific CD8+ cytotoxic T lymphocytes (CTL). Here we present for the Epstein-Barr virus (EBV) BZLF1 a novel strategy that facilitates protein translocation into antigen-presenting cells by its solubilisation in high molar urea and subsequent pulsing of cells in presence of low molar urea. Stimulation of PBMC from HLA-matched EBV-seropositive individuals with urea-treated BZLF1 but not untreated BZLF1 induces an efficient reactivation of BZLF1-specific CTL. Urea-treated BZLF1 (uBZLF1) enters antigen-presenting cells in a temperature-dependent manner by clathrin-mediated endocytosis and is processed by the proteasome into peptides that are bound to nascent HLA I molecules. Dendritic cells and monocytes but also B cells can cross-present uBZLF1 in vitro. The strategy described here has potential for use in the development of improved technologies for the monitoring of protein-specific CTL.
机译:可溶性细胞外蛋白通常不进入抗原呈递细胞的内源性人类白细胞抗原(HLA)I依赖性呈递途径,从而严重阻碍了它们对蛋白特异性CD8 + 细胞毒性T的重新刺激的适用性。淋巴细胞(CTL)。在这里,我们为爱泼斯坦-巴尔病毒(EBV)BZLF1提出了一种新的策略,该策略通过将其溶解在高摩尔尿素中并随后在低摩尔尿素存在下使细胞搏动来促进蛋白质易位进入抗原呈递细胞。用尿素处理过的BZLF1刺激HLA匹配的EBV血清反应阳性的人的PBMC,但未处理过的BZLF1刺激了BZLF1特异性CTL的有效激活。尿素处理过的BZLF1(uBZLF1)通过网格蛋白介导的内吞作用以温度依赖性方式进入抗原呈递细胞,并被蛋白酶体加工成与新生HLA I分子结合的肽。树突状细胞和单核细胞以及B细胞都可以在体外交叉呈递uBZLF1。本文描述的策略在开发用于监测蛋白特异性CTL的改进技术方面具有潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号